BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35140938)

  • 1. Inhibition of renal fibrosis with a human CXCL9-derived glycosaminoglycan-binding peptide.
    Poosti F; Soebadi MA; Crijns H; De Zutter A; Metzemaekers M; Berghmans N; Vanheule V; Albersen M; Opdenakker G; Van Damme J; Sprangers B; Proost P; Struyf S
    Clin Transl Immunology; 2022; 11(2):e1370. PubMed ID: 35140938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of the GAG-binding CXCL9(74-103) peptide in dinitrofluorobenzene-induced contact hypersensitivity in mice.
    Vanheule V; Crijns H; Poosti F; Ruytinx P; Berghmans N; Gerlza T; Ronsse I; Pörtner N; Matthys P; Kungl AJ; Opdenakker G; Struyf S; Proost P
    Clin Exp Allergy; 2018 Oct; 48(10):1333-1344. PubMed ID: 29978510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.
    Vanheule V; Janssens R; Boff D; Kitic N; Berghmans N; Ronsse I; Kungl AJ; Amaral FA; Teixeira MM; Van Damme J; Proost P; Mortier A
    J Biol Chem; 2015 Aug; 290(35):21292-304. PubMed ID: 26183778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamic observation of enalapril on the expression of TGF-beta1, CTGF, Smad7 and alpha-SMA in rats with unilateral ureteral obstruction].
    Wang L; Ning W; Tao L; Wang L; Peng Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 34(3):252-8. PubMed ID: 19349682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of TRPM2 reduces renal fibrosis and inflammation through blocking TGF-β1-regulated JNK activation.
    Wang Y; Chen L; Wang K; Da Y; Zhou M; Yan H; Zheng D; Zhong S; Cai S; Zhu H; Li Y
    Biomed Pharmacother; 2019 Dec; 120():109556. PubMed ID: 31655312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro.
    Chiang CK; Sheu ML; Lin YW; Wu CT; Yang CC; Chen MW; Hung KY; Wu KD; Liu SH
    Br J Pharmacol; 2011 Jun; 163(3):586-97. PubMed ID: 21265825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction.
    Qiao X; Wang L; Wang Y; Zhao N; Zhang R; Han W; Peng Z
    Nephrology (Carlton); 2015 Nov; 20(11):820-31. PubMed ID: 26014968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of fluorofenidone on renal interstitial fibrosis in rats with unilateral ureteral obstruction].
    Tan W; Wang W; Zheng X; Chen J; Yuan X; Zhang F; Wang S; Tao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):511-519. PubMed ID: 29886467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
    Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
    Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
    Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
    Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
    Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.
    Vieira JM; Mantovani E; Rodrigues LT; Dellê H; Noronha IL; Fujihara CK; Zatz R
    Nephrol Dial Transplant; 2005 Aug; 20(8):1582-91. PubMed ID: 15855201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis.
    Yokoi H; Mukoyama M; Sugawara A; Mori K; Nagae T; Makino H; Suganami T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
    Am J Physiol Renal Physiol; 2002 May; 282(5):F933-42. PubMed ID: 11934704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Study on the Role and Mechanism of Fenofibrate in Mice Renal Fibrosis Induced by Unilateral Ureteral Obstruction].
    Xu SS; Li S; Zhang XX; Qi JZ; Li GY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Sep; 51(5):670-674. PubMed ID: 32975082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ClC-5 alleviates renal fibrosis in unilateral ureteral obstruction mice.
    Yang SX; Zhang ZC; Bai HL
    Hum Cell; 2019 Jul; 32(3):297-305. PubMed ID: 31054069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
    Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
    Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney.
    Ma FY; Han Y; Ozols E; Chew P; Vesey DA; Gobe GC; Morais C; Lohman RJ; Suen JY; Johnson DW; Fairlie DP; Nikolic-Paterson DJ
    Nephrology (Carlton); 2019 Sep; 24(9):983-991. PubMed ID: 31314137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
    Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
    PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.